Nordea Investment Management Ab Rocket Pharmaceuticals, Inc. Transaction History
Nordea Investment Management Ab
- $103 Billion
- Q2 2025
A detailed history of Nordea Investment Management Ab transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 263,746 shares of RCKT stock, worth $801,787. This represents 0.0% of its overall portfolio holdings.
Number of Shares
263,746
Previous 254,405
3.67%
Holding current value
$801,787
Previous $1.7 Million
61.91%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding RCKT
# of Institutions
248Shares Held
107MCall Options Held
558KPut Options Held
177K-
Rtw Investments, LP New York, NY17.7MShares$53.8 Million1.93% of portfolio
-
Wellington Management Group LLP Boston, MA12.6MShares$38.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$20.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18.8 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$15.8 Million0.68% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $230M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...